Guru Ownership Trend
Guru Analysis for Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.67 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $724,943.62 net inflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Cliff Asness reduced exposure by 40.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Kymera Therapeutics, Inc. (KYMR)
Major holders include Ken Fisher ($1.46 M), Cliff Asness ($1.09 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 22,273 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $724,943.62, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KYMR. The total reported sell value was $735,034.38.
Yes, 1 managers opened new positions in KYMR, and 0 increased their existing holdings. The total reported buy value was $1.46 M.